Kirkland & Ellis represented GTCR on the deal. GTCR, a leading private equity firm, has announced the closing of GTCR Fund XIV (“Fund XIV” or the “Fund”),...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Eversource Energy on the sale. Eversource has agreed to sell its 50 percent interest in a currently uncommitted lease area of approximately...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters. Fiserv, Inc., a global leader in payments and financial technology, has announced a SEC-registered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advising Clearway Energy Group in financing and sale of California Solar and Storage Projects Clearway Energy Group, LLC closed approximately US$1 billion of debt...
You must be a Standard 1 Year member to access this content.
Goodwin advised ReNAgade Therapeutics on the fundraising. ReNAgade Therapeutics announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures. ReNAgade has...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised National Amusements Inc. on the deal. National Amusements, Inc, the majority voting shareholder of Paramount Global, announced that it has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Starry Group Holdings on uncontested plan of reorganization. Starry Group Holdings, Inc., a fixed wireless broadband internet service provider, received confirmation by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Embark Technology on the transaction, while Goodwin Procter advised Applied Intuition. Applied Intuition, Inc., a tooling and software provider for autonomous vehicle development,...
You must be a Standard 1 Year member to access this content.
Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved. Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises eFFECTOR Therapeutics in US$7.5 million registered direct offering. eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Seagate on the offering, while Davis Polk advised Morgan Stanley & Co. LLC. Seagate HDD Cayman (the “Company”), a subsidiary of Seagate Technology...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
You must be a Standard 1 Year member to access this content.
